Back

Gender differences in the response to spironolactone in chronic systolic heart failure patients: a propensity matched analysis

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Chronic heart failure – pathophysiology and mechanisms Systolic Ventricular Dysfunction ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mrs May Khateeb

King Abdul Aziz Medical City, Jeddah (Saudi Arabia)

14 More presentations in this session

Presentation thumbnail
Appropriate hemoglobin levels in HFpEF patients: results of Japanese heart failure syndrome with preserved ejection fraction (JASPER) registry
Doctor K. Okuno (Philadelphia, US)
Abstract
Presentation thumbnail
Impact of left ventricular pressure overload on relaxation and stiffness in patients with preserved ejection fraction: noninvasive study using speckle tracking echocardiography
Doctor S. Minatoguchi (Gifu, JP)
Abstract
Presentation thumbnail
Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling.
Doctor E. Dal Canto (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Angiotensin converting enzyme 2 activity predicts outcome in heart failure with preserved ejection fraction
Ms C. Binder (Vienna, AT)
Abstract
Presentation thumbnail
Renin activity is an independent predictor of outcome in patients with heart failure and preserved ejection fraction independent of RAAS blocker therapy
Ms C. Binder (Vienna, AT)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Chronic heart failure – pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on vascular (dys)function in the failing heart
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources